| Abstract P078 – Table 1. Comparison of the outcomes of rapid ART initiation among PLWHIV in the pre‐COVID era (2018 to 2019) and the COVID era (2020 to 2021). | |||
|---|---|---|---|
| Pre‐COVID‐19 era (2018 to 2019) (n = 287) | COVID‐19 era (2020 to 2021) (n = 292) | p‐value | |
| Characteristics | |||
| Age, mean (SD) | 32.4 (8.8) | 31.8 (9.2) | 0.451 |
| MSM, n (%) | 263 (91.6) | 265 (90.8) | 0.671 |
| CD4 count cells/mm3, median (IQR) | 270 (122 to 422) | 250 (91 to 426) | 0.357 |
| CD4 counts <200 cells/mm3, n (%) | 101 (35.7) | 121 (42.0) | 0.121 |
| PVL ≥5 log10 copies/mL, n (%) | 122 (43.0) | 158 (54.1) | 0.007 |
| Same‐day ART initiation, n (%) | 126 (43.9) | 188 (64.4) | <0.001 |
| Week 24 outcomes, n (%) | |||
| Death | 3 (1.1) | 3 (1.0) | >0.999 |
| Loss to follow‐up | 6 (2.1) | 3 (1.0) | 0.336 |
| Virologic failure/rebound | 0 | 0 | − |
| Retention in care (including transferral of care) | 277 (96.5) | 285 (97.6) | 0.749 |
| Retention in care but missing week 24 blood testing | 17/263 (6.5) | 63/271 (23.3) | <0.001 |
| PVL <200 copies/mLa | 287/287 (100) | 282/289 (97.6) | 0.015 |
| PVL <50 copies/mLa | 269/286 (94.4) | 254/281 (90.3) | 0.082 |
| Week 48 outcomes, n (%) | |||
| Death | 5 (1.7) | 5 (1.9) | >0.999 |
| Loss to follow‐up | 10 (3.5) | 7 (2.7) | 0.631 |
| Virologic failure/rebound | 0 | 2 (0.8) | − |
| Retention in care (including transferral of care) | 272 (94.8) | 246 (94.7) | >0.999 |
| Retention in care but missing week 48 blood testing | 12/253 (4.7) | 60/230 (34.8) | <0.001 |
| PVL <200 copies/mLa | 287/287 (100) | 290/291 (99.7) | >0.999 |
| PVL <50 copies/mLa | 280/287 (97.6) | 273/291 (93.8) | 0.126 |
aLast‐observation‐carried‐forward analysis.